Zusammenfassung
Unter den kardialen Organmanifestationen der arteriellen Hypertonie ist die linksventrikuläre Hypertrophie die augenscheinlichste und am meisten bekannte. Über Struktur und Funktion des rechten Ventrikels bei der arteriellen Hypertonie gibt es dagegen nur wenige Befunde. Die bisher publizierten Studien zeigen, dass der rechte Ventrikel bei der systolischen arteriellen Hypertonie auch beteiligt ist. Diese Beteiligung des rechten Ventrikels bei der arteriellen Hypertonie impliziert eine Hypertrophie der freien Wand des rechten Ventrikels, eine Störung der diastolischen Füllung des rechten Ventrikels, eine Erhöhung des rechtsventrikulären Füllungsdrucks sowie eine Erniedrigung der rechtsventrikulären Auswurffraktion im fortgeschrittenen Stadium der Hypertonie. Ursächlich für diese strukturellen und funktionellen Veränderungen des rechten Ventrikels sind wahrscheinlich die Fortleitung der erhöhten LV-Füllungsdrucke in die Pulmonalstrombahn, die Interaktion von rechtem und linkem Ventrikel und die systemische Zirkulation von Zytokinen und Wachstumshormonen im Rahmen der Hochdruckerkrankung wie Angiotensin II, Aldosteron u. a.
Abstract
Left ventricular hypertrophy is the best known and most evident cardiac organ manifestation of arterial hypertension. However, only limited findings are available on function and structure of the right ventricle. The published studies show that the right ventricle is also affected in the course of hypertensive heart disease. Particularly hypertrophy of the right ventricular free wall, impaired right ventricular diastolic filling, elevated right ventricular filling pressure as well as impairment of right ventricular ejection fraction in the late phase of arterial hypertension were reported. Possible causes of these structural and functional changes of the right ventricle are (1) translation of the increased left ventricular filling pressure in the pulmonary circulation, (2) interaction of the right and left ventricle, and (3) systemic circulation of cytokines and growth hormones such as angiotensin II, aldosterone, and others.
Literatur
Akkoç A, Uçaman B, Kaymak H et al. (1999) Right and left ventricular diastolic filling parameters in essential hypertension. Asian Cardiovasc Thorac Ann 7:214–220
Chakko S, Marchena E, Kessler KM et al. (1990) Right ventricular diastolic function in systemic hypertension. Am J Cardiol 65:1117–1120
Chobanian AV, Bakris GL, Black HR et al. (2003) The seventh Report of the Joint National Committee on Prevention, Detection and Evaluation and Treatment of High Blood Pressure.The JNC 7 Report. JAMA 289:2534–2573
Dawber TR, Kannel WB (1966) The Framingham study. An epidemiological approach to coronary heart disease. Circulation Oct 34:553–555
Ferlinz J (1980) Right ventricular performance in essential hypertension. Circulation 61:156–162
Isobe M, Yazaki Y, Takaku F et al. (1987) Right ventricular filling detected by pulsed wave Doppler echocardiography during the convalescent stage of inferior wall acute myocardial infarction. Am J Cardiol 59:1245–1250
Julius S (1993) Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21:886–893
Katz AM (1990) Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med 322:100–110
Kelm M, Feelisch M, Krebber T et al. (1995) Role of nitric oxide in the regulation of coronary vascular tone in heart from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension 25:186–193
Levy D, Garrison RJ, Savage DD et al. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham study. N Engl J Med 322:1561–1566
ALLHAT Officers and Coordinators for ALLHAT (2003) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997
Motz W, Vogt M, Rabenau O et al. (1991) Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 68:996–1003
Motz W, Vogt M, Mildenberger E et al. (1991) Koronare Mikrozirkulation bei Patienten mit arterieller Hypertonie: Hinweise für eine gestörte Endothelfunktion. In: Ganten D, Mall G (Hrsg) Herz-Kreislauf-Regulation, Organprotrektion und Organschäden. Schattauer, Stuttgart New York
Myslinsky W, Mosiewickz J, Ryczak E et al. (1998) Right ventricular function in systemic hypertension. J Hum Hypertens 12:149–155
Okamoto M, Kinoshita N, Miyatake K et al. (1983) Analyses oder „Analysis“ of diastolic filling of the right ventricle in hypertrophic cardiomyopathy: a study with two-dimensional Doppler echocardiography. J Cardiography 13:79–88
Olivari MT, Fiorentini C, Polese A, Guazzi MD (1978) Pulmonary hemodynamics and right ventricular function in hypertension. Circulation 57:1185–1190
Querejeta R, Varo N, Lopez B et al. (2000) Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101:1729–1735
Quyyumi AA, Mulcahy D, Andrews NP et al. (1997) Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia: comparison of acetylcholine and substance P. Circulation 95:104–110
Schwartzkopff B, Motz W, Knauer S et al. (1992) Morphometric investigation of intramyocardial arterioles in right septal endomyocardial biopsy of patients with arterial hypertension and left ventricular hypertrophy. J Cardiovasc Pharmacol 20 [Suppl 1]:S12–S17
Schwartzkopff B, Motz W, Frenzel H et al. (1993) Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 88:993–1003
Scheler S, Motz W, Strauer BE (1994) Mechanism of angina pectoris with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol 73(7):478–482
Spring A, Kosmola W, Jolda-Mydlowska B, Witkowska M (1998) Right ventricular diastolic dysfunction and its relation to left ventricular performance in patients with hypertension. J Hum Hypertens 12:149–155
Stamler J, Stamler R, Neaton JD (1993) Blood pressure systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 153:598–615
Strauer BE (1979) Myokardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 44:999–1006
Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44:999–1006
Strauer BE (1981) The heart in hypertension. Springer, Berlin Heidelberg New York
Strauer BE (1990) The significance of coronary reserve in clinical heart disease. J Am Coll Cardiol 15:775–783
Weber KT, Janicki JS, Pick R et al. (1987) Collagen in the hypertrophied pressure-overloaded myocardium. Circulation 75:140–147
Weber KT, Brilla CG (1991) Pathologic hypertrophy and interstitium fibrosis and renin-angiotension-aldosterone system. Circulation 83:1849–1865
Zeiher AM, Drexler H, Wollschlager H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391–401
Zoghbi WA, Habib G, Quinones MA (1990) Doppler assessment of right ventricular filling in a normal population: comparison with left ventricular filling dynamics. Circulation 82:1316–1324
Neubaur T, Schwartzkopff B, Strauer BE (1992) Right ventricular performance in arterial hypertension. Eur Heart J 13 Suppl D:33–38
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Motz, W. Rechter Ventrikel bei arterieller Hypertonie. Internist 45, 1108–1116 (2004). https://doi.org/10.1007/s00108-004-1273-9
Issue Date:
DOI: https://doi.org/10.1007/s00108-004-1273-9